Intuitive Surgical, Inc. $ISRG Shares Sold by Carnegie Lake Advisors LLC

Carnegie Lake Advisors LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 86.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,221 shares of the medical equipment provider’s stock after selling 7,854 shares during the period. Intuitive Surgical accounts for about 0.4% of Carnegie Lake Advisors LLC’s investment portfolio, making the stock its 28th largest holding. Carnegie Lake Advisors LLC’s holdings in Intuitive Surgical were worth $496,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Main Street Group LTD acquired a new position in Intuitive Surgical in the first quarter valued at $30,000. North Point Portfolio Managers Corp OH purchased a new position in Intuitive Surgical during the third quarter worth about $27,000. John Boyer Inc. purchased a new position in Intuitive Surgical during the third quarter worth about $27,000. Compass Wealth Management LLC acquired a new stake in Intuitive Surgical in the 3rd quarter worth about $29,000. Finally, Evergreen Advisors LLC acquired a new stake in Intuitive Surgical in the 1st quarter worth about $35,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, Director Gary Guthart sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the transaction, the director directly owned 1,194,530 shares in the company, valued at $546,306,350.20. This trade represents a 0.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 61 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the transaction, the executive vice president directly owned 581 shares in the company, valued at $256,569.60. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 49,128 shares of company stock valued at $21,614,167 over the last three months. Insiders own 0.60% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

Intuitive Surgical Price Performance

ISRG stock opened at $452.80 on Monday. The company has a market cap of $156.96 billion, a price-to-earnings ratio of 54.75, a PEG ratio of 3.12 and a beta of 1.45. The business has a fifty day simple moving average of $409.93 and a 200-day simple moving average of $431.89. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the firm earned $2.40 earnings per share. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. As a group, analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. Royal Bank Of Canada cut their price objective on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a report on Wednesday, October 21st. Citigroup decreased their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Finally, Mizuho lowered their target price on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $493.54.

About Intuitive Surgical